Anticonvulsants: Aspects of their mechanisms of action

European Journal of Pain

Volumn 6, Issue SUPPL. 1, 2002, Pages 3-9

  Söderpalm, Bo ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CYCLIC AMP; CYCLIC GMP; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LITHIUM; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; VOLTAGE GATED SODIUM CHANNEL; GLUTAMIC ACID; SODIUM CHANNEL;

ANALGESIA; BIPOLAR DISORDER; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; EPILEPSY; GABAERGIC SYSTEM; HUMAN; LONG TERM CARE; MANIA; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NEUROPATHIC PAIN; NEUROTRANSMISSION; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; METABOLISM; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; ANTICONVULSANTS; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; NEURAL INHIBITION; SODIUM CHANNELS; SYNAPTIC TRANSMISSION;

EID: 0036365537     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.2001.0315     Document Type: Article

References (22)

1. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol 1978; 2: 159-175.
2. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000; 57: 95-97.
3. Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME, Huang SC, Wu HM, Maidment K, Baxter LR Jr. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res 1999; 91: 127-139.
4. Brody AL, Barsom MW, Bota RG, Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin Clin Neuropsychiatry 2001; 6: 102-112.
5. Chen G, Hasanat KA, Bebchuk JM, Moore GJ, Glitz D, Manji HK. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom Med 1999; 61: 599-617.
6. Diehl DJ, Gershon S. The role of dopamine in mood disorders. Comp Psychiatry 1992; 33: 115-120.
7. Drevets WC. Functional neuroimaging studies of depression: the anatomy of melancholia. Ann Rev Med 1998; 49: 341-361.
8. Duman RS. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998; 44: 324-335.
9. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
10. Grasby PM. Imaging strategies in depression. J Psychopharmacol 1999; 13: 346-351.
11. Hansen HC. Treatment of chronic pain with antiepileptic drugs: a new era. South Med J 1999; 92: 642-649.
12. Johannessen CU. Mechanisms of action of valproate: a commentatory. Neurochem Int 2000; 37: 103-110.
13. Löscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 1998a; 342: 1-13.
14. Löscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 1998b; 58: 31-59.
15. Manji HK, Lenox RH. Ziskind-Sommerfeld research award - protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manicdepressive illness. Biol Psychiatry 1999; 46: 1328-1351.
16. Mishory A, Yaroslavsky Y, Bersudsky Y, Belmaker RH. Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 2000; 157: 463-465.
17. Nestler EJ. Molecular neurobiology of drug addiction. Neuropsychopharmacology 1994; 11: 77-87.
18. Post RM, Weiss SRB. Kindling and manic-depressive illness. In: Bolwig TG, Trimble MR, eds. The Clinical Relevance of Kindling. Chichester: John Wiley & Sons Ltd, 1989: 209-230.
19. Post RM, Weiss SRB. Kindling: implications for the course and treatment of affective disorders. In: Modigh K, Robak OH, Vestergaard P, eds. Anticonvulsants in Psychiatry. Petersfield: Wrightson Biomedical Publishing Ltd, 1994: 113-137.
20. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990; 42: 223-286.
21. Shimizu T, Shibata M, Wakisaka S, Inoue T, Mashimo T, Yoshiya I. Intrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy. Pain 2000; 85: 59-64.
22. Silverstone T. Dopamine in manic depressive illness. A pharmacological synthesis. J Affect Disord 1985; 8: 225-231.